respiratory
Research

Superheroes tackle infections at TSANZSRS 2019

The Gold Coast is famous for its theme parks, so perhaps it won’t be strange to see Super Heroes fronting up to the final event of the TSANZSRS Annual Scientific Meeting. The Thoracic Society of Australia and New Zealand (TSANZ) and...

The Gold Coast is famous for its theme parks, so perhaps it won’t be strange to see Super Heroes fronting...

Read more
Lung cancer

Room to improve care for stage lll NSCLC

The lung cancer multidisciplinary team (MDT) is critical to best practice and better outcomes in patients with stage lll non-small cell lung cancer (NSCLC). However, according to a review article in the Asia-Pacific Journal of Clinical Oncology, only about half...

The lung cancer multidisciplinary team (MDT) is critical to best practice and better outcomes in patients with stage lll non-small...
Cystic fibrosis

New CF drug gets TGA approval

The TGA has approved a new cystic fibrosis treatment tezacaftor/ivacaftor (Symdeko) for patients aged 12 and older. Manufacturer Vertex announced  on 12 March that its drug (tezacaftor 100 mg/ivacaftor 150 mg tablet and ivacaftor 150 mg tablets) had been ...

The TGA has approved a new cystic fibrosis treatment tezacaftor/ivacaftor (Symdeko) for patients aged 12 and older. Manufacturer Vertex announced...
Asthma

Head to head biologics trial addresses ‘age discrimination’ in severe asthma

The paediatric respiratory community in the UK is to address “age discrimination” against children with severe asthma, announcing plans to undertake a pragmatic clinical trial that will compare biologics in children with severe therapy-resistant asthma (STRA) and assess the benefits...

The paediatric respiratory community in the UK is to address “age discrimination” against children with severe asthma, announcing plans to...